Geode Capital Management
MEDS

Geode Capital Management’s DataMeds AI MEDS Stock Holding History

Geode Capital Management’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Sell
12,467
-1,748
-12% -$8.6K ﹤0.01% 4288
2026
Q1 		$68.5K Buy
14,215
+4,467
+46% +$61.3K ﹤0.01% 4235
2025
Q4 		$195K Buy
9,748
+4,364
+81% +$128K ﹤0.01% 3914
2025
Q3 		$239K Buy
+5,384
New +$284K ﹤0.01% 3864

Other funds holding MEDS

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Geode Capital Management's MEDS Position: Q2 2026 in Review

Geode Capital Management reduced its DataMeds AI (MEDS) stake by 12% in Q2 2026, selling an estimated $8.6K and leaving 12,467 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4288.

Geode Capital Management first reported a position in MEDS in Q3 2025 and has held it in 4 quarters since. The position peaked at $239K in Q3 2025. 9 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

  • Geode Capital Management held 12,467 shares of DataMeds AI worth $38.6K as of Q2 2026.
  • Geode Capital Management sold 1,748 DataMeds AI shares in Q2 2026, an estimated $8.6K.
  • DataMeds AI made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4288 holding.
  • Geode Capital Management first reported a position in DataMeds AI in Q3 2025 and has held it in 4 quarters since.
  • Geode Capital Management's DataMeds AI position peaked at $239K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held DataMeds AI as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.